Ignite Creation Date:
2024-05-06 @ 8:57 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02860286
Status:
COMPLETED
Last Update Posted:
2021-04-09
First Post:
2016-07-27
Brief Title:
Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Sponsor:
Epizyme Inc
Organization:
Epizyme Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Mesothelioma |
| BAP1 Loss of Function |
Keywords: